Physiomics secures new modelling contract with Numab Therapeutics

Simcere Pharmaceutical enter licence and collaboration agreement with Boehringer Ingelheim

Insilico Medicine's ISM8969 receives US FDA IND approval for Parkinson's Disease

NeuroSense Therapeutics granted US patent protection for use of PrimeC combination in Alzheimer's disease

LEO Pharma advances delgocitinib cream into phase 3 trial for lichen sclerosus

HistoIndex partners Houston Research Institute

Formosa Pharmaceuticals licenses APP13007 ophthalmic therapy to Samil for South Korea

Eli Lilly agrees to acquire Ventyx Biosciences

Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial

Hoth Therapeutics files two US provisional patent applications to establish oncology-focused dermatology platform

Elanco Animal Health's Befrena (tirnovetmab) receives USDA approval for canine dermatitis

Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11

Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA

Alvotech launches first-in-market golimumab biosimilar in Europe

Physiomics secures follow-on UK contract for Phase 2 study support